Details
Category: Volume 05 Issue 10 October 2017
Hits: 2910

Title: Role of Antiplatelet Drugs in Deep Vein Thrombosis

Author: Dr Ishtyak Ahmed Mir, Dr Noor Ali, Dr Arvind Kohli, Dr Vivek Gandhotra, Dr Mohit Arora, Dr Babar Rashid

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i10.34

Abstract

Background: Acute and chronic venous diseases are the most prevalent medical conditions worldwide. Acute venous thromboembolism is a serious and frequently lethal disease, whereas chronic venous insufficiency can be the source of discomfort, disability and loss of working days. Deep vein thrombosis and its further complications are very well known. Despite the best possible management, morbidity and mortality cannot be prevented in all.

Material and Methods: The study was conducted in the department of Cardiovascular and Thoracic Surgery of a super-specialty hospital. All the patients admitted in the department, referred from or examined in other departments, and attended in our outpatient department, irrespective of age, sex, disease, and who followed the department for at least one year were included in the study. Vascular doppler of the affected limb was the investigation of choice. Acenocaumarol, aspirin were the commonly used anticoagulant and antiplatelet drugs

Results: 13.66% of the patients never came for follow up, 12.94% were managed by other departments, 58.82% were from the inpatient and 41.17 from the outpatient department. Pain and edema limb were the most common symptoms. Vascular doppler helped confirming diagnosis in all. Parenteral anticoagulants during the early course of treatment, simultaneous addition of oral anticoagulant drugs, were the first line of treatment. Oral anticoagulants combined with antiplatelet drugs was the commonly used combination in majority of the patients. 

Conclusion: Antiplatelet added right from the inception for first few weeks, and during follow-up, especially in patients at high risk, those who can’t effort low molecular weight heparin, those who don’t get blood tests regularly and in those who can’t effort regular follow up. Low dose antiplatelet drugs help in decreasing progression of the disease and decrease morbidity and mortality.

Keywords: Deep vein thrombosis, Acenocaumarol, Aspirin, Clopidogrel.

 

References

  1. Raskob G: Calf-vein thrombosis. In Hull RD, Raskob GE, Pineo GF, (eds): Venous Thromboembolism: An Evidence-based Atlas. Armonk, NY Futura Publishing Company, 1996, p 307.
  2. Hull RD, Raskob GE, Hirsh J: Prophylaxis of venous thromboembolism: An overview. Chest 1986; 89 (5 suppl): 374.
  3. Campbell CB, Chandler JG, Tegtmeyer CJ, et al. Axillary, subclavian and brachi-ocephalic obstruction. Surgery 1977; 82(6): 816.
  4. Strandness DE, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA 1983; 250(10): 1289.
  5. O’Brien MF, Stafford EG, Gardner MA, et al. Allograft aortic valve replacement long term follow-up. Ann ThoracSurg 1995; 60(suppl): S65-70.
  6. A Janelle Hermosillo, Sarah A spinler. Aspirin, Clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous? The Annals of Pharmacotherapy 2008; 42(6): 790-805.
  7. Porter A, Konstantino Y, Lakabishvili Z, Shachar l, Battler A, Hasdai D. Short-term triple therapy with aspirin, warfarin and thienopyridine among patients undergoing percutaneous coronary interventions. Catheter cardiovascinterv 2006; 68: 56-61.
  8. Karjalainen PP, PorelaP, Ylitalo A, et al. safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting. Eur Heart J 2007; 28: 726-732.
  9. Steele P, Ellis J, Genton E. Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis. Am J Med 1978; 64: 441-445.
  10. Hight D, Tilney N, Couch N. Changing clinical trends in patients with peripheral emboli. Surgery 1976; 79: 172.
  11. Fowkes FJ, Fowkes FG. Incidence of diagnosed deep vein thrombosis in general population, systematic review. Eur J vascEndovasc 2003; 251: 1-5.
  12. Prandoni P, Bernaardi E, Marchiori A, Lensing AW, Prins MH, villalta S, Bagatella P, sartor D, Piccioli A, Simioni p, Pagnan A, Girolami A. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ 2004; 329: 484.
  13. Modarai B, Burnand KG, Humphries J, Waltham M, Smith A. The role of neovascularization in the resolution of venous thrombus. Thromb Haemost 2005; 93: 801-809.
  14. Saarinen J, Kallio T, Lehto M, Hiltunen S, Sisto T. The occurrence of post-thrombotic changes after an acute deep venous thrombosis. A prospective two-year follow-up study. J CardiovascSurg (Torino) 2000; 41: 441-446.
  15. Patterson BO, Hinchliffe R, Loftus IM, Thompson MM, Holt PJ. Indications for catheter directed thrombolysis in the management of acute proximal deep venous thrombosis. Arterioscler Thromb VascBiol 2010; 30: 669-674.
  16. Wakefield TW, Strieter RM, Prince MR, Downing LJ, Greenfield LJ. Pathogenesis of venous thrombosis; a new insight. Cardiovasc Surg 1997; 5: 6-15.
  17. BucekRAReiter M, Quehenberger P, Minar E. C-reactive protein in the diagnosis of deep vein thrombosis. Br J Haematol 2002; 119: 385-389.
  18. Jibu J Joseph, Anand Pillai, Diana Bramley. Clopidogrel in orthopaedic patients: a review of current practice in Scotland. Thrombosis journal 2007; 5: 6.
  19. Guidance for the treatment of deep Vein Thrombosis and pulmonary embolism. Michael B. streiff, Giancarlo Agnelli, Jean M Connors, Mark Crowther, Sabine Eichinger, Renato Lopes, Robert D McBane, Stephen Moll. J Thromb Thrombolysis 2016; 41: 32-67.
  20. Cecilia Becattini, Giancarlo Agnelli, Alessandro Schenone, Sabine Eichinger, Eugenio Bucherini, Mauro Silingardi, Marina Bianchi, Marco Moia, Walter Ageno, Maria Rita Vandelli, Elvira Grandone, Paolo Prandoni. Aspirin for Preventing the Recurrence of Venous Thromboembolism. The New England Journal of Medicine 2012, Vol. 366, No. 21, 1959 to 1967.
  21. Timothy Abrighton, John W Eikelboom, kristy Mann, M Biostat, Rebecca Mister, Alexander Gallus, Paul Ockelford, Harry Gibbs, Wendy Hague, Denis Xavier, Rafael Diaz, Adrienne Kirby, John Simes. Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism. N Engl J Med 2012, Vol. 367; No. 22: 1979-1987.
  22. M M C Hovens, J D Snoep, J T Tamsma, M V Huisman. Aspirin in the prevention and treatment of venous thromboembolism. Journal of Thrombosis and Haemostasis; 4: 1470-1475.
  23. Ymer H Mekaj, Fetije T Daci, Agon Y Mekaj. New insights into the mechanism of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism. TherClin Risk Manag 2015; 11; 1449-1456.

Corresponding Author

Dr Ishtyak Ahmed Mir

Umar Colony, Back-Side of Forest Nursery, Sidhra, Jammu, Jammu and Kashmir State, India Pincode 180019

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Phone No. 9419081019